Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
1,268
1,268 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- vudalimabPhase 22 trials
Xencor, Inc. · Ovarian Cancer, Clear Cell Carcinoma, Endometrial Cancer
- WGI-0301Phase 22 trials
Zhejiang Haichang Biotech Co., Ltd. · Advanced Hepatocellular Carcinoma (HCC), Hepato Cellular Carcinoma (HCC), Renal Cell Cancer
- WJB001Phase 22 trials
Wigen Biomedicine Technology (Shanghai) Co., Ltd. · Advanced Solid Tumor, Advanced Solid Tumors
- XNW27011ASP546CPhase 22 trials
Astellas · Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic
- YL202 should be intravenously infusedPhase 22 trials
MediLink Therapeutics (Suzhou) Co., Ltd. · NSCLC, Breast Cancer, HNSCC
- ZalifrelimabPhase 22 trials
ImmunoGenesis · Metastatic Prostate Cancer, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Cancer
- ZEN003694ZEN-3694Phase 22 trials
Zenith Epigenetics · mCRPC, Metastatic Castration-Resistant Prostate Cancer
- ZGGS18Phase 22 trials
Suzhou Zelgen Biopharmaceuticals Co.,Ltd · Advanced Solid Tumor
- A group Purinostat MesylatePhase 21 trial
Chengdu Zenitar Biomedical Technology Co., Ltd · Advanced Solid Tumor
- AB-2100Integrated Circuit T cellsPhase 21 trial
Arsenal Biosciences, Inc. · Advanced/Metastatic Clear Cell Renal Cell Carcinoma, Recurrence
- AB680Phase 21 trial
Arcus Biosciences, Inc. · Metastatic Colorectal Cancer
- ABL103Phase 21 trial
ABL Bio, Inc. · Solid Tumors
- ABO2011ABOD2011Phase 21 trial
Suzhou Abogen Biosciences Co., Ltd. · Solid Tumor, Adult
- ABP1011TPhase 21 trial
Shanghai AB PharmaTech Ltd. · SCLC, Extensive Stage, Advanced Solid Tumors
- ABSK141Phase 21 trial
Abbisko Therapeutics Co, Ltd · Solid Tumors, Adult
- ABT-101DBPR112Phase 21 trial
Anbogen Therapeutics, Inc. · Advanced Solid Tumor, Non Small Cell Lung Cancer, HER2 Mutations
- ACE-86225106Phase 21 trial
Acerand Therapeutics (Shanghai) Limited · Solid Tumor, Adult, BRCA1 Mutation, BRCA2 Mutation
- ACR-2316Phase 21 trial
Acrivon Therapeutics · Specific Advanced Solid Tumors
- ACR-368prexasertibPhase 21 trial
Acrivon Therapeutics · Endometrial Adenocarcinoma
- ACT001Phase 21 trial
Accendatech USA Inc. · Recurrent Glioblastoma Multiforme(GBM)
- AD1208Phase 21 trial
Avelos Therapeutics Inc. · Solid Tumor, Adult, Tumor, Solid, Solid Tumor
- AdAPT-001Phase 21 trial
EpicentRx, Inc. · Solid Tumor, Adult, Cancer, Neoplasms
- adebeliizumabPhase 21 trial
Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Non-small Cell Lung Cancer
- ADI-212Phase 21 trial
Adicet Therapeutics · Prostate Cancer Metastatic
- AFNT-211Phase 21 trial
Affini-T Therapeutics, Inc. · Pancreatic Ductal Adenocarcinoma, Non-Small Cell Lung Cancer, Colorectal Cancer
- AGS 22M6EAGS-22CEPhase 21 trial
Merck & Co. · Bladder Cancer
- AI-081Phase 21 trial
OncoC4, Inc. · Advanced Solid Tumor
- Aldoxorubicin HClPhase 21 trial
ImmunityBio, Inc. · Pancreatic Cancer
- ALK202Phase 21 trial
Shanghai Allink Biotherapeutics Co., Ltd. · NSCLC (Advanced Non-small Cell Lung Cancer)
- ALMB-0168Phase 21 trial
AlaMab Therapeutics (Shanghai) Inc. · Advanced Solid Tumors With Bone Only Metastasis
- Alomnertinib MesilatePhase 21 trial
Shanghai Hengrui Pharmaceutical Co., Ltd. · Non-small Cell Lung Cancer
- AMO959BY1298, BY101298Phase 21 trial
Novartis · PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
- AMP945Phase 21 trial
Amplia Therapeutics Limited · Pancreatic Cancer, PDAC, Pancreatic Ductal Adenocarcinoma
- AMT-253Phase 21 trial
Multitude Therapeutics Inc. · Malignant Melanoma, Advanced Solid Tumors
- AMT-676Phase 21 trial
Multitude Therapeutics Inc. · Colorectal Cancer
- AMXI-5001Phase 21 trial
AtlasMedx, Incorporated · Advanced Malignant Neoplasm, Breast Cancer, Ovarian Cancer
- and CarboplatinPhase 21 trial
CrystalGenomics, Inc. · Non Squamous Non Small Cell Lung Cancer
- ANO31905Phase 21 trial
Anova Innovation Limited · Pancreatic Cancer
- ANS014004Phase 21 trial
Beijing Pearl Biotechnology Limited Liability Company · Non-Small Cell Lung Cancer, EGFR Mutation, Metastatic Lung Cancer
- ANS02Phase 21 trial
Avistone Biotechnology Co., Ltd. · Non-Small Cell Lung Cancer
- ANV600Phase 21 trial
Anaveon AG · Advanced Solid Tumor
- AP203Phase 21 trial
AP Biosciences Inc. · Locally Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC)
- AP402Phase 21 trial
AP Biosciences Inc. · Advanced Solid Tumor
- APL-101Phase 21 trial
Apollomics Inc. · Solid Tumors, Advanced Cancer, Renal Cancer
- ART0380Phase 21 trial
Artios Pharma Ltd · Advanced Cancer, Metastatic Cancer, Ovarian Cancer
- ART6043Phase 21 trial
Artios Pharma Ltd · Advanced Solid Tumor, Metastatic Solid Tumor
- ARV-6723Phase 21 trial
Arvinas Inc. · Advanced Solid Tumor
- ARV-806Phase 21 trial
Arvinas Inc. · KRAS G12D Mutation, Advanced Solid Cancer
- ARX788Phase 21 trial
Ambrx, Inc. · HER2 Positive Metastatic Breast Cancer
- AS1986NSPhase 21 trial
Antelope Surgical Solutions, Inc · Prostate Cancer, Prostate Cancer (Adenocarcinoma), Fluorescence Imaging
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.